167 related articles for article (PubMed ID: 30093515)
1. Sociodemographic and psychological determinants of influenza vaccine intention among recipients of autologous and allogeneic haematopoietic stem cell transplant: a cross-sectional survey of UK transplant recipients using a modified health belief model.
Miller PDE; Forster AS; de Silva TI; Leonard H; Anthias C; Mayhew M; Klammer M; Paskar S; Hurst E; Peggs K; Madrigal A; Snowden JA
BMJ Open; 2018 Aug; 8(8):e021222. PubMed ID: 30093515
[TBL] [Abstract][Full Text] [Related]
2. A comparison of viral microneutralization and haemagglutination inhibition assays as measures of seasonal inactivated influenza vaccine immunogenicity in the first year after reduced intensity conditioning, lymphocyte depleted allogeneic haematopoietic stem cell transplant.
Miller PDE; de Silva TI; Leonard H; Anthias C; Hoschler K; Goddard K; Peggs K; Madrigal A; Snowden JA
Vaccine; 2019 Jan; 37(3):452-457. PubMed ID: 30554797
[TBL] [Abstract][Full Text] [Related]
3. Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients.
Morishita S; Kaida K; Yamauchi S; Wakasugi T; Ikegame K; Kodama N; Ogawa H; Domen K
Eur J Oncol Nurs; 2015 Oct; 19(5):443-50. PubMed ID: 25911269
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.
Sharma A; Bhatt NS; St Martin A; Abid MB; Bloomquist J; Chemaly RF; Dandoy C; Gauthier J; Gowda L; Perales MA; Seropian S; Shaw BE; Tuschl EE; Zeidan AM; Riches ML; Shah GL
Lancet Haematol; 2021 Mar; 8(3):e185-e193. PubMed ID: 33482113
[TBL] [Abstract][Full Text] [Related]
5. The Impact of the COVID-19 Pandemic on the Uptake of Influenza Vaccine: UK-Wide Observational Study.
Bachtiger P; Adamson A; Chow JJ; Sisodia R; Quint JK; Peters NS
JMIR Public Health Surveill; 2021 Apr; 7(4):e26734. PubMed ID: 33651708
[TBL] [Abstract][Full Text] [Related]
6. Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study.
Piñana JL; Pérez A; Montoro J; Giménez E; Gómez MD; Lorenzo I; Madrid S; González EM; Vinuesa V; Hernández-Boluda JC; Salavert M; Sanz G; Solano C; Sanz J; Navarro D
Clin Infect Dis; 2019 May; 68(11):1894-1903. PubMed ID: 30239624
[TBL] [Abstract][Full Text] [Related]
7. A survey of infectious diseases and vaccination uptake in long-term hematopoietic stem cell transplant survivors in Australia.
Dyer G; Gilroy N; Brice L; Kabir M; Gottlieb D; Huang G; Hogg M; Brown L; Greenwood M; Larsen SR; Moore J; Hertzberg M; Tan J; Ward C; Kerridge I
Transpl Infect Dis; 2019 Apr; 21(2):e13043. PubMed ID: 30585673
[TBL] [Abstract][Full Text] [Related]
8. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
[TBL] [Abstract][Full Text] [Related]
9. Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey.
Gratwohl A; Schmid O; Baldomero H; Horisberger B; Urbano-Ispizua A;
Bone Marrow Transplant; 2004 Nov; 34(10):855-75. PubMed ID: 15517006
[TBL] [Abstract][Full Text] [Related]
10. Intention to have the seasonal influenza vaccination during the COVID-19 pandemic among eligible adults in the UK: a cross-sectional survey.
Sherman SM; Sim J; Amlôt R; Cutts M; Dasch H; Rubin GJ; Sevdalis N; Smith LE
BMJ Open; 2021 Jul; 11(7):e049369. PubMed ID: 34257095
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients.
Ambati A; Einarsdottir S; Magalhaes I; Poiret T; Bodenstein R; LeBlanc K; Brune M; Maeurer M; Ljungman P
Transpl Infect Dis; 2015 Jun; 17(3):371-9. PubMed ID: 25817044
[TBL] [Abstract][Full Text] [Related]
12. Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.
Winston DJ; Mullane KM; Cornely OA; Boeckh MJ; Brown JW; Pergam SA; Trociukas I; Žák P; Craig MD; Papanicolaou GA; Velez JD; Panse J; Hurtado K; Fernsler DA; Stek JE; Pang L; Su SC; Zhao Y; Chan ISF; Kaplan SS; Parrino J; Lee I; Popmihajlov Z; Annunziato PW; Arvin A;
Lancet; 2018 May; 391(10135):2116-2127. PubMed ID: 29856344
[TBL] [Abstract][Full Text] [Related]
13. Influenza vaccination and intention to receive the pandemic H1N1 influenza vaccine among healthcare workers of British Columbia, Canada: a cross-sectional study.
Kaboli F; Astrakianakis G; Li G; Guzman J; Donovan T; Naus M
Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1017-24. PubMed ID: 20707670
[TBL] [Abstract][Full Text] [Related]
14. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
15. Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial.
Krishnan A; Pasquini MC; Logan B; Stadtmauer EA; Vesole DH; Alyea E; Antin JH; Comenzo R; Goodman S; Hari P; Laport G; Qazilbash MH; Rowley S; Sahebi F; Somlo G; Vogl DT; Weisdorf D; Ewell M; Wu J; Geller NL; Horowitz MM; Giralt S; Maloney DG;
Lancet Oncol; 2011 Dec; 12(13):1195-203. PubMed ID: 21962393
[TBL] [Abstract][Full Text] [Related]
16. Disparities in parental awareness of children's seasonal influenza vaccination recommendations and influencers of vaccination.
Tuckerman J; Crawford NW; Marshall HS
PLoS One; 2020; 15(4):e0230425. PubMed ID: 32271793
[TBL] [Abstract][Full Text] [Related]
17. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
[TBL] [Abstract][Full Text] [Related]
18. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005.
Youssef S; Rodriguez G; Rolston KV; Champlin RE; Raad II; Safdar A
Medicine (Baltimore); 2007 Mar; 86(2):69-77. PubMed ID: 17435587
[TBL] [Abstract][Full Text] [Related]
19. Editor's Choice: Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey.
Kwok KO; Li KK; Wei WI; Tang A; Wong SYS; Lee SS
Int J Nurs Stud; 2021 Feb; 114():103854. PubMed ID: 33326864
[TBL] [Abstract][Full Text] [Related]
20. Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantation.
Gueller S; Allwinn R; Mousset S; Martin H; Wieters I; Herrmann E; Serve H; Bickel M; Bug G
Biol Blood Marrow Transplant; 2011 Oct; 17(10):1546-50. PubMed ID: 21324375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
